Trombola 25 mg (Tablet)
Unit Price: ৳ 500.00 (1 x 7: ৳ 3,500.00)
Strip Price: ৳ 3,500.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Eltrombopag olamine |
| Company | Ziska pharmaceuticals ltd |
| Also available as |
Product Title
Categories
- Medicine
- Pharmaceuticals
- Healthcare
- Hematology
Description
- Small molecule thrombopoietin (TPO) receptor agonist
- Indicated for thrombocytopenia, immune thrombocytopenia, hepatitis C associated thrombocytopenia, severe aplastic anemia
- Oral route of administration
- Dosage varies based on condition and age
- Interacts with TPO-receptor to induce platelet production
- Contraindicated in known hypersensitivity
- Common side effects: anemia, nausea, pyrexia, ALT increased, cough, fatigue, headache, diarrhea
- No sufficient data on use during pregnancy and lactation
- Increased risk of hepatic decompensation in chronic hepatitis C patients
- Increased risk of progression of myelodysplastic syndromes to acute myeloid leukemia
- Portal vein thrombosis reported in chronic liver disease patients
- Monitor liver function and platelet counts regularly
- Safety and efficacy not established in pediatric patients below 1 year
Dimensions
Color Options
Functions
- Stimulates platelet production
- Chelation of eltrombopag in case of overdose
- Regulates platelet count
Materials
Technical Specifications
- Initiate at a low dose, then titrate based on response
- Dosing adjustments for patients of Asian ancestry or with hepatic impairment
- Take at least 2 hours before or 4 hours after certain medications and foods
Design Elements
Usability Features
- Easy oral administration
- Store in cool and dry place
- Protected from light
Interactions
- Interaction with medications containing polyvalent cations
- Interaction with calcium-rich foods
Contraindications
- Hypersensitivity to eltrombopag or its components
Side Effects
- Anemia
- Nausea
- Pyrexia
- ALT increased
- Cough
- Fatigue
- Headache
- Diarrhea
Pregnancy & Lactation
- No sufficient data for use during pregnancy
- Not recommended during breastfeeding
Precautions & Warnings
- Increased risk of hepatic decompensation in chronic hepatitis C patients
- Increased risk of myelodysplastic syndromes progression to acute myeloid leukemia
- Portal vein thrombosis reported in chronic liver disease patients
- Monitor liver function and platelet counts regularly
Use in Special Populations
- Safety and efficacy not established in pediatric patients below 1 year
- Safety and efficacy not established in pediatric patients with certain conditions
Overdose Effects
- Excessive increase in platelet counts
- Thrombotic or thromboembolic complications
- Chelation of eltrombopag to limit absorption
Therapeutic Class
- Haemostatic drugs
Storage Conditions
- Cool (below 25°C) and dry place
- Protected from light
- Keep away from the reach of children